首页 / 院系成果 / 成果详情页

Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse  期刊论文  

  • 编号:
    96a97d0e-2b24-4106-84d0-0175e213a8b2
  • 作者:
    Chan, Anthony W. H.[1];Yu, Shuangni[2];Yu, YauHei[1];Tong, Joanna H. M.[1,3,4];Wang, Lei(王磊)[5,6]Tin, Edith K. Y.[1];Chong, Charing C. N.[7];Chan, Stephen L.[3,8];Wong, Grace L. H.[3,9];Wong, Vincent W. S.[3,9];Chan, Henry L. Y.[3,9];Lai, Paul B. S.[3,7];To, KaFai[1,3,4];
  • 语种:
    English
  • 期刊:
    HISTOPATHOLOGY ISSN:0309-0167 2016 年 69 卷 6 期 (971 - 984) ; DEC
  • 收录:
  • 关键词:
  • 摘要:

    AimsSteatosis in hepatocellular carcinoma (HCC) has been recognized for decades and found most commonly in small, well-differentiated HCC. However, the clinicopathological features and pathogenesis of HCC with steatosis is not well characterized. There are few data concerning whether HCC with steatosis should be regarded a distinct histological variant, steatotic HCC. Methods and resultsA retrospective cohort of 516 patients undergoing curative surgery for primary HCC was recruited. The median follow-up was 45.5 (range: 0.2-166.0) months. Steatotic HCC was defined as HCC with significant steatosis (5% of tumour cells). Associations with immunohistochemical expression of fatty acid binding protein-1 (FABP1), sonic hedgehog (SHH) and gene polymorphism of patatin-like phospholipase 3 (PNPLA3) were analysed. Steatotic HCC was found in 21.1% of patients and was associated with higher metabolic risks [diabetes mellitus (36.7% versus 18.2%) and hypertension (44.0% versus 28.7%)], underlying fatty liver (60.6% versus 37.8%), steatohepatitis (30.3% versus 13.0%), smaller tumour size, lower frequency of major vessel (1.8% versus 11.3%) and microvascular invasion (20.2% versus 32.4%), earlier tumour stages and lower serum alpha-fetoprotein. It was associated with developing late tumour relapse (hazard ratio 2.15, P = 0.002) independently of underlying cirrhosis and non-anatomical excision. Steatotic HCC did not differ from HCC without significant steatosis in immunohistochemical expression of FABP1 and SHH and PNPLA3 gene polymorphism. ConclusionSteatotic HCC is a common histological variant of HCC with distinct association with underlying fatty liver, steatohepatitis and metabolic risks. Despite more favourable baseline tumour features, it was associated with late tumour relapse.

  • 推荐引用方式
    GB/T 7714:
    Chan Anthony W. H.,Yu Shuangni,Yu Yau-Hei, et al. Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse [J].HISTOPATHOLOGY,2016,69(6):971-984.
  • APA:
    Chan Anthony W. H.,Yu Shuangni,Yu Yau-Hei,Tong Joanna H. M.,&To Ka-Fai.(2016).Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse .HISTOPATHOLOGY,69(6):971-984.
  • MLA:
    Chan Anthony W. H., et al. "Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse" .HISTOPATHOLOGY 69,6(2016):971-984.
浏览次数:3 下载次数:0
浏览次数:3
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部